Search Results - "Sindu, Devika"

Late-Onset Exudative Pleural Effusions Without Concomitant Airway Obstruction or Lung Parenchymal Abnormalities: A Novel Presentation of Chronic Lung Allograft Dysfunction by Sindu, Devika, Bansal, Sandhya, Buddhdev, Bhuvin, McAnally, Kendra, Mohamed, Hesham, Walia, Rajat, Mohanakumar, Thalachallour, Tokman, Sofya

“…Restrictive allograft syndrome (RAS) is an aggressive variant of CLAD characterized by progressive restrictive ventilatory decline and persistent…”
Get full text

Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience by Razia, Deepika, Sindu, Devika, Cherrier, Lauren, Grief, Katherine, Walia, Rajat, Tokman, Sofya

“…Remdesivir (REM) and molnupiravir (MOL) are commonly used to treat lung transplant recipients (LTRs) with COVID-19; however, the clinical efficacy of these…”
Get full text

Clinical utility of plasma percent donor-derived cell-free DNA for lung allograft surveillance: A real-world single-center experience by Sindu, Devika, Bay, Curt, Grief, Katherine, Walia, Rajat, Tokman, Sofya

“…Plasma percent donor-derived cell-free DNA (%dd-cfDNA) has been investigated as a biomarker of allograft injury after lung transplantation. We sought to…”
Get full text

Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection by Sindu, Devika, Razia, Deepika, Grief, Katherine, Cherrier, Lauren, Omar, Ashraf, Walia, Rajat, Tokman, Sofya

“…Lung transplant recipients (LTRs) have an increased risk of COVID-19-related morbidity and mortality. Tixagevimab-cilgavimab (tix-cil) is a long-acting…”
Get full text

PERFORMANCE OF PLASMA PERCENT DONOR-DERIVED CELL-FREE DNA FOR LUNG ALLOGRAFT SURVEILLANCE >1 YEAR POSTTRANSPLANT: A REAL-WORLD SINGLE CENTER EXPERIENCE by SINDU, DEVIKA, GRIEF, KATHERINE, WALIA, RAJAT, TOKMAN, SOFYA

Get full text

ORGANIZING PNEUMONIA: WHAT IS THE CULPRIT? by SINDU, DEVIKA, TOKMAN, SOFYA, WALIA, RAJAT, BUDDHDEV, BHUVIN M

Get full text

SIMULTANEOUS INVASIVE MUCORMYCOSIS AND POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN A LUNG TRANSPLANT RECIPIENT RECEIVING BELATACEPT: THE PERILS OF IMMUNOSUPPRESSION by SINDU, DEVIKA, BISWAS ROY, SREEJA, BUDDHDEV, BHUVIN M, MOHAMED, HESHAM E, PHAM, CHRISTINE, TOKMAN, SOFYA

Get full text

PULMONARY ALLOGRAFT KAPOSI SARCOMA PRESENTING AS MULTIPLE PULMONARY NODULES IN A LUNG TRANSPLANT RECIPIENT DUE TO POSSIBLE DONOR-DERIVED HUMAN HERPESVIRUS-8 by SINDU, DEVIKA, BUDDHDEV, BHUVIN M, MOHAMED, HESHAM E, BREMNER, ROSS, TOKMAN, SOFYA

Get full text

PRIMARY PLEURAL EFFUSION POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN A LUNG TRANSPLANT RECIPIENT: AN UNUSUAL PRESENTATION by SINDU, DEVIKA, BISWAS ROY, SREEJA, ABDELRAZEK, HESHAM, MOHAMED, HESHAM E, TOKMAN, SOFYA

Get full text

HIDDEN EXPLANT CANCERS IN LUNG TRANSPLANT RECIPIENTS by SINDU, DEVIKA, MOIN, ARIBA, MOHAMED, HESHAM E, WALIA, RAJAT, ARJUNA, ASHWINI

Get full text

MEDICAL MANAGEMENT OF INVASIVE PULMONARY MUCORMYCOSIS IN LUNG TRANSPLANT RECIPIENTS: ATTAINING A CURE WITHOUT SURGERY by SINDU, DEVIKA, ARJUNA, ASHWINI, MCANALLY, KENDRA J, ABDELRAZEK, HESHAM, BUDDHDEV, BHUVIN M, WALIA, RAJAT, TOKMAN, SOFYA, MOHAMED, HESHAM E

Get full text

SPONTANEOUS REVERSAL OF BRONCHOSCOPIC LUNG VOLUME REDUCTION AFTER 2 YEARS by SINDU, DEVIKA, ALBARAZI, MOHIEDDIN, YUVARAJ, RAGUL, MOORE, AMY L, LATORRE-RODRIGUEZ, ANDRES R, KHOKAR, ABID I, SAEED, ALI I

Get full text

THE UNKNOWNS OF REPEATING CHEMICAL PLEURODESIS by SINDU, DEVIKA, YUVARAJ, RAGUL, MOORE, AMY L, LATORRE-RODRIGUEZ, ANDRES R, ALBARAZI, MOHIEDDIN, KHOKAR, ABID I, SAEED, ALI I

Get full text

Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience by Sindu, Devika, Razia, Deepika, Bay, Curt, Padiyar, Josna, Grief, Katherine, Buddhdev, Bhuvin, Arjuna, Ashwini, Abdelrazek, Hesham, Mohamed, Hesham, McAnally, Kendra, Omar, Ashraf, Walia, Rajat, Schaheen, Lara, Tokman, Sofya

“…Lung transplant recipients (LTRs) are at increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19); however, the disease course has…”
Get full text

Prior SARS-CoV-2 infection may not alter the clinical course of COVID-19 in lung transplant recipients: A single-center experience by Sindu, Devika, Razia, Deepika, Grief, Katherine, Cherrier, Lauren, Omar, Ashraf, Walia, Rajat, McAnally, Kendra, Buddhdev, Bhuvin, Tokman, Sofya

“…In the general population, prior infection with SARS-CoV-2 reduces the risk of severe COVID-19; however, studies in lung transplant recipients (LTRs) are…”
Get full text

Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients by Martinez, Sydni, Sindu, Devika, Nailor, Michael D., Cherrier, Lauren, Tokman, Sofya, Walia, Rajat, Goodlet, Kellie J.

“…Background Lung transplant recipients are at high risk for severe cytomegalovirus (CMV) disease. Off‐label use of letermovir (LET) may avert myelotoxicity…”
Get full text

Effect of different instrumentation techniques on students’ performance and outcomes of nonsurgical root canal treatment by Medina‐Torres, Luis, Cochran, Clarence, Bauer, Patricia Ann, Valcanaia, Andre Joao, Sindu, Devika, Cavalcanti, Bruno, McDonald, Neville

“…Objectives This study compared, retrospectively, the incidence of clinical errors and effects on treatment outcomes, when students were exposed to two…”
Get full text

TREND, PREVALENCE, AND OUTCOMES OF ACUTE VENOUS THROMBOEMBOLISM AMONGST US HOSPITALIZATIONS - A CROSS-SECTIONAL STUDY by Bag, Soumyadeep, Patra, Tumpa, Kelangi, Sarah Susan, Kpadenou, Vihoale, Regassa, Henok Dereje, Jerry, Merilyn, Sindu, Devika, Erva, Snigdha, Hsieh, Ya-Ching, Puli, Srikanth, Panghal, Ritvika, Gujarathi, Rahul, Patel, Urvish, Thakkar, Badal Girishbhai

Get full text